These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 33785249)

  • 1. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role.
    Samuel SM; Varghese E; Büsselberg D
    Trends Microbiol; 2021 Oct; 29(10):894-907. PubMed ID: 33785249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the interaction between COVID-19 and diabetes mellitus.
    Chee YJ; Tan SK; Yeoh E
    J Diabetes Investig; 2020 Sep; 11(5):1104-1114. PubMed ID: 32558211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing.
    Varghese E; Samuel SM; Liskova A; Kubatka P; Büsselberg D
    PLoS Pathog; 2021 Jun; 17(6):e1009634. PubMed ID: 34157054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential.
    Kamyshnyi O; Matskevych V; Lenchuk T; Strilbytska O; Storey K; Lushchak O
    Biomed Pharmacother; 2021 Dec; 144():112230. PubMed ID: 34628168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
    Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
    Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Metformin in Patients With Type 2 Diabetes With COVID-19: A Preliminary Retrospective Report.
    Gao Y; Liu T; Zhong W; Liu R; Zhou H; Huang W; Zhang W
    Clin Transl Sci; 2020 Nov; 13(6):1055-1059. PubMed ID: 32955785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review.
    Plowman TJ; Christensen H; Aiges M; Fernandez E; Shah MH; Ramana KV
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes.
    Crouse AB; Grimes T; Li P; Might M; Ovalle F; Shalev A
    Front Endocrinol (Lausanne); 2020; 11():600439. PubMed ID: 33519709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
    Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and diabetes: A bidirectional relationship.
    Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
    Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic ketoacidosis and COVID-19: what have we learned so far?
    de Sá-Ferreira CO; da Costa CHM; Guimarães JCW; Sampaio NS; Silva LML; de Mascarenhas LP; Rodrigues NG; Dos Santos TL; Campos S; Young EC
    Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E44-E53. PubMed ID: 34779657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality.
    Stafford EG; Riviere JE; Xu X; Kawakami J; Wyckoff GJ; Jaberi-Douraki M
    J Am Pharm Assoc (2003); 2020; 60(6):e145-e152. PubMed ID: 32561317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metformin: one of the possible options to reduce the mortality of severe coronavirus disease 2019?].
    Pan Y; Han R; He Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1131-1134. PubMed ID: 33081905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
    Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019.
    Hayden MR
    J Int Med Res; 2020 Jul; 48(7):300060520939746. PubMed ID: 32722979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and COVID-19: review of a lethal interaction from the cellular and molecular level to the bedside.
    Ali Kazem T; Zeylabi F; Filayih Hassan A; Paridar P; Pezeshki SP; Pezeshki SMS
    Expert Rev Endocrinol Metab; 2022 Jan; 17(1):1-19. PubMed ID: 34781797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury.
    Chen X; Guo H; Qiu L; Zhang C; Deng Q; Leng Q
    Front Immunol; 2020; 11():2056. PubMed ID: 32973814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.